SLC12A2 and ischemia: Some studies have shown that administration of the NKCC1 blocker bumetanide can attenuate the cell swelling and injury, suggesting that sodium and chloride transport via NKCC1 is involved in ischemia-induced cell swelling and injury [17,18].